Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
opc-28326 | adrenergic receptor alpha-1d | NA | Successful target | TTD | Peripheral Vascular Diseases[MeSHID:D016491] Raynaud Disease[MeSHID:D011928] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | discontinued in phase 2 | unknown |
opc-28326 | alpha-2b adrenergic receptor | small molecule | NA | drugbank , DGIDB | Peripheral Vascular Diseases[MeSHID:D016491] Raynaud Disease[MeSHID:D011928] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational | unknown |
opc-28326 | alpha-2c adrenergic receptor | small molecule | NA | drugbank , DGIDB | Peripheral Vascular Diseases[MeSHID:D016491] Raynaud Disease[MeSHID:D011928] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational | unknown |
opc-28326 | 5-hydroxytryptamine receptor 2b | small molecule | NA | drugbank | Peripheral Vascular Diseases[MeSHID:D016491] Raynaud Disease[MeSHID:D011928] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational | unknown |
click here to return to the previous page |